PAUL W WALKER

TitleAssociate Professor
InstitutionMD Anderson
DepartmentPalliative Care & Rehabilitation Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Naqash AR, Ricciuti B, Owen DH, Florou V, Toi Y, Cherry C, Hafiz M, De Giglio A, Muzaffar M, Patel SH, Sugawara S, Burkart J, Park W, Chiari R, Sugisaka J, Otterson GA, de Lima Lopes G, Walker PR. Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunol Immunother. 2020 07; 69(7):1189. PMID: 32347358.
      Citations:    Fields:    
    2. Sehgal K, Bulumulle A, Brody H, Gill RR, Macherla S, Qilleri A, McDonald DC, Cherry CR, Shea M, Huberman MS, VanderLaan PA, Weiss GJ, Walker PR, Costa DB, Rangachari D. Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer. Clin Lung Cancer. 2020 Jun 05. PMID: 32653295.
      Citations: 1     Fields:    
    3. Naqash AR, Ricciuti B, Owen DH, Florou V, Toi Y, Cherry C, Hafiz M, De Giglio A, Muzaffar M, Patel SH, Sugawara S, Burkart J, Park W, Chiari R, Sugisaka J, Otterson GA, de Lima Lopes G, Walker PR. Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunol Immunother. 2020 Jul; 69(7):1177-1187. PMID: 32140762.
      Citations: 2     Fields:    Translation:Humans
    4. Migliorini D, Dutoit V, Allard M, Grandjean Hallez N, Marinari E, Widmer V, Philippin G, Corlazzoli F, Gustave R, Kreutzfeldt M, Blazek N, Wasem J, Hottinger A, Koka A, Momjian S, Lobrinus A, Merkler D, Vargas MI, Walker PR, Patrikidou A, Dietrich PY. Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients. Neuro Oncol. 2019 07 11; 21(7):923-933. PMID: 30753611.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    5. Naqash AR, Appah E, Yang LV, Muzaffar M, Marie MA, Mccallen JD, Macherla S, Liles D, Walker PR. Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition. J Immunother Cancer. 2019 07 05; 7(1):169. PMID: 31277704.
      Citations: 4     Fields:    Translation:Humans
    6. Naqash AR, Stroud CRG, Butt MU, Dy GK, Hegde A, Muzaffar M, Yang LV, Hafiz M, Cherry CR, Walker PR. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database. Acta Oncol. 2018 06; 57(6):867-872. PMID: 29241410.
      Citations: 5     Fields:    Translation:Humans
    7. Naqash AR, Yang LV, Sanderlin EJ, Atwell DC, Walker PR. Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report. Acta Oncol. 2018 05; 57(5):705-708. PMID: 29171332.
      Citations: 5     Fields:    Translation:Humans
    8. Biswas T, Efird JT, Prasad S, Jindal C, Walker PR. The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer. Oncotarget. 2017 Dec 22; 8(68):112712-112719. PMID: 29348858.
      Citations: 10     Fields:    
    9. Dutoit V, Migliorini D, Ranzanici G, Marinari E, Widmer V, Lobrinus JA, Momjian S, Costello J, Walker PR, Okada H, Weinschenk T, Herold-Mende C, Dietrich PY. Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma. Oncoimmunology. 2018; 7(2):e1391972. PMID: 29308320.
      Citations:    
    10. Hui D, Frisbee-Hume S, Wilson A, Dibaj SS, Nguyen T, De La Cruz M, Walker P, Zhukovsky DS, Delgado-Guay M, Vidal M, Epner D, Reddy A, Tanco K, Williams J, Hall S, Liu D, Hess K, Amin S, Breitbart W, Bruera E. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial. JAMA. 2017 09 19; 318(11):1047-1056. PMID: 28975307.
      Citations: 18     Fields:    Translation:Humans
    11. Kalman NS, Weiss E, Walker PR, Rosenman JG. Local Radiotherapy Intensification for Locally Advanced Non-small-cell Lung Cancer - A Call to Arms. Clin Lung Cancer. 2018 01; 19(1):17-26. PMID: 28712978.
      Citations: 2     Fields:    Translation:Humans
    12. Prasad S, Efird JT, James SE, Walker PR, Zagar TM, Biswas T. Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women. Springerplus. 2016; 5(1):756. PMID: 27386241.
      Citations:    
    13. Karvinen KH, Vallance J, Walker PR. Newly diagnosed lung cancer patients' preferences for and beliefs about physical activity prior to chemotherapy. Psychol Health Med. 2016 Jul; 21(5):593-600. PMID: 26813963.
      Citations: 3     Fields:    Translation:Humans
    14. Hui D, dos Santos R, Reddy S, Nascimento MS, Zhukovsky DS, Paiva CE, Dalal S, Costa ED, Walker P, Scapulatempo HH, Dev R, Crovador CS, De La Cruz M, Bruera E. Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study. Palliat Med. 2015 Oct; 29(9):826-33. PMID: 25881622.
      Citations: 9     Fields:    Translation:Humans
    15. Karvinen KH, Esposito D, Raedeke TD, Vick J, Walker PR. Effect of an exercise training intervention with resistance bands on blood cell counts during chemotherapy for lung cancer: a pilot randomized controlled trial. Springerplus. 2014; 3:15. PMID: 24683529.
      Citations:    
    16. Zhang J, Gay HA, Russo S, Parent T, Aljumaily R, Walker PR. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer. Lung Cancer. 2014 Jan; 83(1):67-72. PMID: 24246506.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    17. Karvinen KH, McGourty S, Parent T, Walker PR. Physical activity promotion among oncology nurses. Cancer Nurs. 2012 May-Jun; 35(3):E41-8. PMID: 21946904.
      Citations: 11     Fields:    Translation:Humans
    18. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller TP, Palla SL, Rhondali W, Kang JH, Kim SH, Del Fabbro E, Zhukovsky DS, Reddy S, Elsayem A, Dalal S, Dev R, Walker P, Yennu S, Reddy A, Bruera E. The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist. 2011; 16(11):1642-8. PMID: 21976316.
      Citations: 21     Fields:    Translation:Humans
    19. Quan WD, Gagnon GA, Walker PR, Quan FM. Pulse interleukin-2 with famotidine induces CD56+ lymphocytes in the peripheral blood of patients with metastatic melanoma or kidney cancer. Cancer Biother Radiopharm. 2011 Feb; 26(1):65-7. PMID: 21348776.
      Citations: 1     Fields:    Translation:HumansCells
    20. Yennurajalingam S, Dev R, Walker PW, Reddy SK, Bruera E. Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases. J Pain Symptom Manage. 2010 May; 39(5):930-5. PMID: 20471553.
      Citations: 3     Fields:    Translation:Humans
    21. Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, Bruera E. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med. 2010 Jan; 13(1):33-8. PMID: 19824814.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    22. Quan WD, Walker PR, Picton M, Quan FM, King LA, Tyre C, Liles DK. High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma. Cancer Biother Radiopharm. 2008 Oct; 23(5):641-6. PMID: 18999936.
      Citations:    Fields:    Translation:HumansCells
    23. Walker PW, Palla S, Pei BL, Kaur G, Zhang K, Hanohano J, Munsell M, Bruera E. Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med. 2008 Oct; 11(8):1103-8. PMID: 18980450.
      Citations: 16     Fields:    Translation:Humans
    24. Walker PW, Bruera E, Boohene J. Managing high dose sufentanil in a suffering patient. J Pain Symptom Manage. 2008 Jul; 36(1):e1-4. PMID: 18538537.
      Citations:    Fields:    Translation:Humans
    25. Quan WD, Quan FM, King LA, Walker PR. Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. Cancer Biother Radiopharm. 2008 Feb; 23(1):108-13. PMID: 18298334.
      Citations: 2     Fields:    Translation:Humans
    26. Del Fabbro E, Reddy SG, Walker P, Bruera E. Palliative sedation: when the family and consulting service see no alternative. J Palliat Med. 2007 Apr; 10(2):488-92. PMID: 17472523.
      Citations: 4     Fields:    Translation:Humans
    27. Quan WD, Milligan KS, Quan FM, Cuenca RE, Khan N, Liles DK, Walker PR. Continuous infusion interleukin-2 and intravenous famotidine in metastatic melanoma. Cancer Biother Radiopharm. 2006 Dec; 21(6):607-12. PMID: 17257076.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    28. Le Gal FA, Widmer VM, Dutoit V, Rubio-Godoy V, Schrenzel J, Walker PR, Romero PJ, Valmori D, Speiser DE, Dietrich PY. Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors. J Invest Dermatol. 2007 Mar; 127(3):622-9. PMID: 17039243.
      Citations: 4     Fields:    Translation:HumansCells
    29. Quan WD, Walker PR, Quan FM, Ramirez M, Elsamaloty HM, Ghai V, Vinogradov M, Liles DK. Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2. Cancer Biother Radiopharm. 2006 Oct; 21(5):437-42. PMID: 17105418.
      Citations:    Fields:    Translation:HumansCells
    30. Quan WD, Vinogradov M, Quan FM, Khan N, Liles DK, Walker PR. Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer. Cancer Biother Radiopharm. 2006 Oct; 21(5):515-9. PMID: 17105423.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    31. Walker PR, Khuder SA, Quan WD. Continuous infusion interleukin-2 and antihistamines in metastatic kidney cancer. Cancer Biother Radiopharm. 2005 Oct; 20(5):487-90. PMID: 16248764.
      Citations:    Fields:    Translation:Humans
    32. Walker P, Neuhauser MN, Tam VH, Willey JS, Palmer JL, Bruera E, Prince RA. Subcutaneous administration of cefepime. J Pain Symptom Manage. 2005 Aug; 30(2):170-4. PMID: 16125032.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    33. Strasser F, Walker P, Bruera E. Palliative pain management: when both pain and suffering hurt. J Palliat Care. 2005; 21(2):69-79. PMID: 16114805.
      Citations: 12     Fields:    Translation:Humans
    34. Elsayem A, Swint K, Fisch MJ, Palmer JL, Reddy S, Walker P, Zhukovsky D, Knight P, Bruera E. Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol. 2004 May 15; 22(10):2008-14. PMID: 15143094.
      Citations: 48     Fields:    Translation:Humans
    35. Roemer-B├ęcuwe C, Vigano A, Romano F, Neumann C, Hanson J, Quan HK, Walker P. Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration. J Pain Symptom Manage. 2003 Sep; 26(3):843-8. PMID: 12967733.
      Citations: 3     Fields:    Translation:Humans
    36. Walker PW, Klein D, Kasza L. High dose methadone and ventricular arrhythmias: a report of three cases. Pain. 2003 Jun; 103(3):321-4. PMID: 12791438.
      Citations: 16     Fields:    Translation:Humans
    37. Walker P. Management of pressure ulcers. Oncology (Williston Park). 2001 Nov; 15(11):1499-508, 1511; discussion1511,1515-6. PMID: 11758876.
      Citations:    Fields:    Translation:Humans
    38. Walker P, Nordell C, Neumann CM, Bruera E. Impact of the Edmonton Labeled Visual Information System on physician recall of metastatic cancer patient histories. a randomized controlled trial. J Pain Symptom Manage. 2001 Jan; 21(1):4-11. PMID: 11223309.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    39. Doyle J, Walker P, Bruera E. Nebulized scopolamine. J Pain Symptom Manage. 2000 May; 19(5):327-8. PMID: 10928852.
      Citations:    Fields:    Translation:Humans
    40. Gagnon B, Bielech M, Watanabe S, Walker P, Hanson J, Bruera E. The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Support Care Cancer. 1999 Jul; 7(4):265-70. PMID: 10423053.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    41. Walker P, Watanabe S, Bruera E. Baclofen, a treatment for chronic hiccup. J Pain Symptom Manage. 1998 Aug; 16(2):125-32. PMID: 9737104.
      Citations: 9     Fields:    Translation:Humans
    42. Lawlor PG, Watanabe S, Walker P, Bruera E. Re: Memorial Delirium Assessment Scale and commentary. J Pain Symptom Manage. 1998 Feb; 15(2):73-5. PMID: 9494304.
      Citations:    Fields:    Translation:Humans
    43. Pereira J, Mancini I, Walker P. The role of bisphosphonates in malignant bone pain: a review. J Palliat Care. 1998; 14(2):25-36. PMID: 9686493.
      Citations:    Fields:    Translation:Humans
    44. Walker P, Watanabe S, Lawlor P, Hanson J, Pereira J, Bruera E. Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity. Ann Oncol. 1997 Sep; 8(9):915-6. PMID: 9358945.
      Citations: 4     Fields:    Translation:Humans
    45. Lawlor P, Walker P, Bruera E, Mitchell S. Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence. J Pain Symptom Manage. 1997 Jun; 13(6):356-61. PMID: 9204657.
      Citations: 11     Fields:    Translation:Humans
    46. Walker P, Watanabe S, Taube A. The Edmonton Staging System. J Pain Symptom Manage. 1996 Nov; 12(5):269. PMID: 8942119.
      Citations:    Fields:    Translation:Humans
    47. Walker P, Watanabe S, Lawlor P, Bruera E. Subcutaneous clodronate. Lancet. 1996 Aug 03; 348(9023):345-6. PMID: 8709722.
      Citations: 1     Fields:    Translation:Humans
    48. Preface. Hematology/Oncology Clinics of North America. 16.
    WALKER's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (202)
    Explore
    _
    Co-Authors (13)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _